Výsledky vyhledávání - "Alexandra Vorontsova"

Long-Term Results and Characteristics of Pleural Effusion in Late Chronic Phase Chronic Myeloid Leukemia Patients at Dasatinib Therapy after Imatinib Failure

Autor: Ekaterina Chelysheva, Oleg Shukhov, Anna G. Turkina, Sergey G. Kuznetsov, Anastasia Bykova, Svetlana Goryacheva, Olga V. Lazareva, Galina Gusarova, Alexandra Vorontsova, Tatyana Ivanova

Publikováno v: Blood. 126:5141-5141

Background. The aim of chronic myeloid leukemia (CML) treatment with tyrosine kinase inhibitors (TKI) is not only effectiveness, but also safety. Long treatment duration makes the analysis of most significant complications very important. Pleural eff

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9f3ae23b59a300713301e28dd116a070
https://doi.org/10.1182/blood.v126.23.5141.5141

Zobrazit plný text záznamu

Clinical Significance of Additional Chromosomal Abnormalities In Ph-Positive and Ph-Negative Cells In Patients with Chronic Myeloid Leukemia Treated by Tyrosine Kinase Inhibitors

Autor: Alexandra Vorontsova, Olga Vinogradova, Ekaterina Chelysheva, Aseeva Ea, Galina Gusarova, Nina Khoroshko, Anna G. Turkina, Olga V. Lazareva

Publikováno v: Blood. 118:1683-1683

Abstract 1683 Introduction. Additional chromosomal abnormalities (ACA) in Ph'-positive (Ph'+) cells firstly described more than 30 years ago were associated with progression of chronic myeloid leukemia (CML) and often were founded in advanced stages

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::773e9a8842523892e80ebeedb92e45fc
https://doi.org/10.1182/blood.v118.21.1683.1683

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání